BHARAT Fundamentals

The fundamental analysis module provides a way for investors to measures BHARAT IMMUNOLOGICALS's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and variouse microeconomic indicators and financial ratios related to BHARAT IMMUNOLOGICALS stock. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Fundamentals 

 
Refresh

BHARAT Current Valuation Analysis

BHARAT IMMUNOLOGICALS's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value 
 = 
Market Cap + Debt 
-  
Cash 
More About Current Valuation | All Equity Analysis

Current BHARAT IMMUNOLOGICALS Current Valuation

    
  251.81 M  
Most of BHARAT IMMUNOLOGICALS's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BHARAT IMMUNOLOGICALS BIOLOG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Compare to competition

In accordance with the recently published financial statements, BHARAT IMMUNOLOGICALS BIOLOG has a Current Valuation of 251.81 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The current valuation for all India stocks is notably lower than that of the firm.

BHARAT IMMUNOLOGICALS Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BHARAT IMMUNOLOGICALS's current stock value. Our valuation model uses many indicators to compare BHARAT IMMUNOLOGICALS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BHARAT IMMUNOLOGICALS competition to find correlations between indicators driving BHARAT IMMUNOLOGICALS's intrinsic value. More Info.
BHARAT IMMUNOLOGICALS BIOLOG is number one stock in return on asset category among related companies. It is number one stock in net income category among related companies .

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

BHARAT Fundamentals

BHARAT IMMUNOLOGICALS Investors Sentiment

The influence of BHARAT IMMUNOLOGICALS's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BHARAT. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - BIBCL

BHARAT IMMUNOLOGICALS Investor Sentiment

Most of Macroaxis users are currently bullish on BHARAT IMMUNOLOGICALS BIOLOG. What is your opinion about investing in BHARAT IMMUNOLOGICALS BIOLOG? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with BHARAT IMMUNOLOGICALS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BHARAT IMMUNOLOGICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BHARAT IMMUNOLOGICALS will appreciate offsetting losses from the drop in the long position's value.

BHARAT IMMUNOLOGICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Twitter and Weibo Corp Ads. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Note that the BHARAT IMMUNOLOGICALS information on this page should be used as a complementary analysis to other BHARAT IMMUNOLOGICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Other Tools for BHARAT IMMUNOLOGICALS Stock

When running BHARAT IMMUNOLOGICALS price analysis, check to measure BHARAT IMMUNOLOGICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BHARAT IMMUNOLOGICALS is operating at the current time. Most of BHARAT IMMUNOLOGICALS's value examination focuses on studying past and present price action to predict the probability of BHARAT IMMUNOLOGICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BHARAT IMMUNOLOGICALS's price. Additionally, you may evaluate how the addition of BHARAT IMMUNOLOGICALS to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go